Hutch News
Results per Page:
New open source software empowers scientists to uncover immune secrets
'Infinity Flow’ adds machine learning to widespread, but limited, technology for analyzing single cells
What happens if the coronavirus’s spikes mutate?
First-of-its-kind study explores how changes in the virus’s ‘lock picks’ could help or hinder its ability to sneak into our cells
$3.4 million grant to find safer, more effective leukemia treatments
New combinatorial targeted therapies before haploidentical bone marrow transplantation for AML could also help expand access to potential cures for underserved populations
Cancer’s toll on the heart decades down the road
New research explores how to lower the risk of heart disease in childhood cancer survivors
$3.5M grant to develop safer treatment for inherited blood disorders
Scientists will study radioactive particles that can precisely deliver a potent punch
New study will track workers at high risk for coronavirus
Volunteers to provide regular samples to help close knowledge gaps in how COVID-19 spreads undetected
A cheaper way to study the immune system, one cell at a time
Scientists describe a more efficient way to sequence individual cells and visualize the massive amount of data that ensues
Inside scorpion venom: A future Rx for arthritis?
Tiny scorpion-derived proteins deliver arthritis drugs to joints in rat study
High-altitude altruism: Seeking cures at 17,600 feet
Fred Hutch scientist, senior leader will hike the Himalayas to raise money for cancer research
99 problems when n=1?
In research, (sample) size matters
Dr. Guang-Shing Cheng receives Dr. Ali Al-Johani Award for exceptional patient care
Pulmonologist’s work honored as ‘invaluable to transplant patients’
Big gains in bone marrow transplant survival since mid-2000s
Despite older, sicker patients, mortality rate dropped by one-third within 10-year period
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy
Gimme shelter: CRISPR hides healthy cells from leukemia drug
In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer
'Keeping these out of the hands of adolescents is critical'
Fred Hutch lung cancer expert testifies as Washington state weighs flavored vaping ban
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Mystery solved: How graft-vs.-host disease starts in the gut
Microbiome triggers top killer after bone marrow transplant — and there’s a potential way to stop it
The link between baby’s cells and mom’s disease risk
Why does mom’s risk for rheumatoid arthritis skyrocket when her baby has a gene that protects against it?
Remembering Dr. Ron Reeder, molecular biologist-turned-photographer
Renaissance man and expert in gene regulation had enduring impact on Fred Hutch’s Basic Sciences Division